SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-075355
Filing Date
2018-12-31
Accepted
2018-12-31 17:13:16
Documents
2
Period of Report
2018-12-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-42107_18k.htm 8-K 26234
2 EX-3.1 a18-42107_1ex3d1.htm EX-3.1 13717
  Complete submission text file 0001104659-18-075355.txt   41223
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 181260288
SIC: 2834 Pharmaceutical Preparations